David Deming

Phio Pharmaceuticals Strengthens Governance with New Lead Director

King of Prussia, Pennsylvania – October 31, 2025 — Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biopharmaceutical company developing...

By cGxPwire Editor
October 31, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

David Deming

Phio Pharmaceuticals Strengthens Governance with New Lead Director